Home > Insider Trading > Filing (0001179110-16-029281)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1113481	Medicines Co	MDCO	Pharmaceutical Preparations (2834)	043324394

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1204787	Clive Meanwell	8 Sylvan Way Parsippany NJ 07054	Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2016-08-31	378	$28.08	339,168	No	4	A	Direct
Common Stock	Acquisiton	2016-09-01	1,377	$28.60	340,545	No	4	M	Direct
Common Stock	Disposition	2016-09-01	1,377	$40.00	339,168	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right-to-buy)	Disposition	2016-09-01	1,377	$0.00	1,377	$28.60

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
68,623		2017-02-16	No	4	M	Direct

Footnotes

Acquired pursuant to The Medicines Company Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period beginning March 1, 2016 and ending August 31, 2016. In accordance with the terms of the ESPP, these shares were purchased based on 85% of the fair market value closing price of the issuer's common stock on March 1, 2016.
Sales were effected pursuant to a Rule 10b-5 program adopted by Dr. Meanwell.
This option vested in forty-eight equal installments beginning on March 16, 2007.
Not applicable.